Hook & thesis
Clear Secure (YOU) is the leading biometric identity platform at airports today but its tech is penetrating enterprise identity, healthcare and media verification. Price has dropped back toward the low $40s after a blistering run earlier this year; technicals show RSI ~32 and MACD in bearish momentum, suggesting a short-term oversold condition. I view this pullback as a buying opportunity for a disciplined swing trade: the business continues to compound members and free cash flow, and the market has room to re-rate when growth and margin power remain visible.
In short: buy the dip at $46.50, size the position so a stop at $41 cushions the trade, and look for a return to $60 as a primary target over the next 45 trading days while keeping a longer-term $72 upside if the company sustains top-line beats and FCF expansion.
What CLEAR does and why it matters
CLEAR builds biometric identity verification technology that links a person's biometric identity to the credentials in their wallet. Today the most visible use is airport security acceleration, but the same identity layers are productized for events, healthcare identity management and secure communications (for example, press-release verification). The business benefits from two durable secular trends:
- Rising demand for frictionless identity in high-frequency travel and live events.
- Enterprise and public-sector interest in stronger authentication tools as phishing and identity fraud rise.
Investors should care because CLEAR is converting user growth into revenue and free cash flow at scale. Recent quarterly disclosures showed the company generated $240.8M in revenue in Q4 2025 (up 17% year-over-year) and adjusted EBITDA of $79.9M (up 58% YoY). Membership expanded sharply - Clear membership grew roughly 32% to 38 million users - giving CLEAR a large and expanding addressable base it can monetize across products and partners.
Concrete numbers that support the thesis
- Current price sits near $47.04 while the 52-week high is $69.07 and the 52-week low is $29.44 - this puts the stock roughly 32% below the high, offering a sizable recovery runway if sentiment normalizes.
- Free cash flow is robust at $508.4M (most recent report) which supports reinvestment and margin expansion without aggressive dilution.
- Valuation metrics on a recent snapshot show a price-to-earnings around 34x and enterprise value-to-sales of ~4.84x, with enterprise value near $4.84B and market capitalization roughly in the mid-single-digit billions.
- Dividend is modest but present: $0.15 per share quarterly, with a yield near 1.9% on recent prices; management is signaling capital allocation discipline while scaling operations.
- Technicals favor a bounce trade: 10/20/50-day SMAs sit in the low-to-mid $50s while the 9-day EMA is $51.44 and RSI is ~32.3, implying short-term oversold conditions.
Valuation framing
CLEAR currently trades at enterprise multiples consistent with high-growth software-like businesses, driven by recurring enrollment and network effects around biometric identity. A price-to-earnings near the mid-30s implies investors are paying for sustained growth and margin expansion; similarly, EV/sales around ~4.8x and EV/EBITDA near 16.9x reflect expectations that revenue and operational leverage will continue to improve.
That said, CLEAR's free cash flow of roughly $508M gives the company a real cash-generation story to underpin valuation. If management delivers the guided free cash flow growth of at least ~28% for the year and revenue continues in the mid-teens growth range (consistent with recent quarterly results showing ~17% revenue growth), the current multiple is reasonable to attractive relative to earlier stages when the company burned more cash.
Catalysts that could drive the rebound
- Continued travel recovery and higher CLEAR+ enrollment among international travelers - CLEAR expanded CLEAR+ to more countries recently, opening additional paid enrollment pools (positive for near-term revenue).
- Enterprise wins and healthcare integrations - agreements like the Tampa General Hospital integration demonstrate a path to recurring B2B revenue beyond airports.
- Product bundling with TSA PreCheck and promotional partnerships - low-cost enrollment promos materially increase the top of funnel and paid conversion.
- Quarterly beats and raised guidance - the stock rallied sharply after the Q4 2025 beat and the company providing optimistic guidance could re-ignite momentum.
Trade plan - actionable buy-the-dip setup
We recommend a swing trade (mid term - 45 trading days) sized to portfolio risk tolerance. The idea is to capture a rebound to the short-to-intermediate moving averages and sentiment re-rating.
| Action | Price | Horizon |
|---|---|---|
| Entry | $46.50 | Mid term (45 trading days) |
| Stop loss | $41.00 | |
| Primary target | $60.00 | Exit on target or tighten stop |
| Stretch target | $72.00 | Hold only with sustained positive catalysts |
Rationale: an entry at $46.50 places you below short-term resistance and near recent intraday lows ($46.41) while offering an asymmetric upside to $60 (roughly 29% upside) with a defined stop at $41 (about 12% downside). The swing window (45 trading days) gives time for membership monetization, a possible earnings/momentum reaction, or product partnership news to re-rate multiples.
Risks and counterarguments
Below are the principal risks that could invalidate the trade.
- Macro or travel slowdown: A renewed downturn in travel demand or a recession would compress CLEAR’s airport-centric revenue and reduce enrollment growth.
- Competition and commoditization: Biometric identity is increasingly crowded. If competitors or platform vendors undercut CLEAR’s pricing or scale similar solutions into airports and events, growth and margins could suffer.
- Execution risk on enterprise expansion: Moving into healthcare and enterprise identity requires sales cycles, integrations and compliance. If wins stall or margins underperform, multiples may compress.
- Sentiment and technical pressure: Short interest remains material (roughly 11.9M shares as of 07/31 with days to cover near 10.5), and high short-volume days can amplify downside in a sell-off.
- Insider selling headlines: Director sales under Rule 10b5-1 plans have shown up in the news; while those sales have been characterized as plan-based, recurring insider dispositions can still create negative sentiment.
Counterargument - A fair critique is that CLEAR already trades at premium multiples (mid-30s P/E, EV/sales ~4.8x) and investors could reasonably prefer to wait for a deeper pullback or for multiple quarters of sustained margin expansion before buying. That view is sensible for buy-and-hold investors who want confirmation; this write-up is a disciplined swing trade, not a blind long-term accumulation.
What would change my mind
I would abandon this trade plan if any of the following occur:
- Membership growth stalls or reverses materially from recent 30%-plus growth rates reported previously.
- Free cash flow guidance is lowered or FCF starts to contract versus the most recent $508M run rate.
- Large, credible competitive entry (from major cloud providers or biometric platform providers) begins to win airport or enterprise deals at scale, undercutting CLEAR's pricing power.
- Price breaks below $41 on heavy volume and fails to re-establish support - that would suggest technical risk outweighs fundamental momentum.
Conclusion
CLEAR is not a momentum trade for the faint-hearted, but the pullback into the high-$40s is a tactical buying window for disciplined swing traders. The company combines membership growth, improving free cash flow and visible enterprise expansion paths. With technicals showing oversold conditions and a clear set of catalysts on the calendar, a measured entry at $46.50 with a $41 stop and a primary target of $60 offers an attractive asymmetric trade: defined downside and meaningful upside if growth and margin trends continue. Tight risk management and attention to travel demand and quarterly results will be critical to executing this plan successfully.
Key data points referenced
- Recent quarter: $240.8M revenue, adjusted EBITDA $79.9M (Q4 2025, reported 02/25/2026).
- Membership: ~38M users, up ~32% year-over-year (reported alongside Q4 2025 results).
- Free cash flow: ~$508.4M (most recent reported figure).
- Technicals: current price ~$47.04, RSI ~32.3, 9-day EMA ~$51.44, 50-day SMA ~$53.74.
- Short interest: ~11.86M shares (settlement 07/31), days to cover ~10.5.